• Home 
• Stocks 
• ETFs 
•  Funds 
•  News 
•  IPOs 
•  Markets 
•  Market Movers 
•  Rates 
•  Futures 
•  Forex 
•  Calendars 
•  Tags 

Get Quote

Advanced Lookup

 

Acorda Therapeutics Inc. (ACOR) Stock Quote

•  
• Quote | 
• Profile | 
• Shares | 
• Ratios | 
• Depth/LII | 
• Options | 
• Charts | 
• News | 
• Financials  

•  
• Insiders | 
• Filings | 
• Analyst | 
• Earnings | 
• Historical | 
• Tags | 
• Updates | 
• Stock Web  

Detailed Quote for Acorda Therapeutics Inc. (ACOR)  $ 25.44   -0.38 (-1.47%) Volume: 626.58 k 4:00 PM EST Feb 10, 2012 After Hours:  $ 25.34   -0.10 (-0.39%) Volume: 900  4:01 PM EST Feb 10, 2012 close 52 Week Information 52 Week High May 31, 2011 Close: 33.48 52 Week Low October 4, 2011 Close: 18.36 Today 5d 1m 3m 1y more Last Price 25.44 Change $ 0.38 Change % 1.47% Tick N/A Bid N/A Bid Size 0 Ask N/A Ask Size 0 Open 25.63 High 26.06 Low 25.07 Prev Close 25.82 Last Trade 2/10/12 Volume 626.58 k 52 Wk Hi 33.48 52 Wk Low 18.36 Market Cap 1.01 b Ex-Div Date N/A Div Rate N/A Yield N/A Shares 39,667,483 EPS (TTM) 0.53 PE Ratio 48.00 close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange NGS

News and Media for Acorda Therapeutics Inc.  (ACOR)  Sector News | Topic News Sector News Basic Materials   - Chemicals   - Energy   - Metals & Mining Conglomerates   - Conglomerates Consumer Goods   - Consumer Durables   - Consumer Non-Durables   - Automotive   - Food & Beverage   - Tobacco Financial   - Banking   - Financial Services   - Insurance   - Real Estate Healthcare   - Drugs   - Health Services Industrial Goods   - Aerospace/Defense   - Manufacturing   - Materials & Construction Services   - Leisure   - Media   - Retail   - Specialty Retail   - Wholesale   - Diversified Services   - Transportation Technology   - Computer Hardware   - Computer Software & Services   - Electronics   - Telecommunications   - Internet Utilities   - Utilities Hide Market News AMEX Nasdaq NYSE OTCBB Pink Sheets Mutual Funds Commodities TSX World Market News Asia Pacific Europe Corporate Actions Stock Buyback Dividends Earnings Stock Splits Insider Trading IPO's Business & Finance Antitrust Banking & Finance Capital Gains Mergers & Acquisitions Economy Consumer Price Index Bond/Stock Update Federal Reserve Foreign Exchange International Monetary Fund Interest Rates Hide News for ACOR Thu, Feb 09, 2012 9:00 AM A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories - Marketwire 6:01 AM Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference - Business Wire 6:00 AM Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 - Business Wire Tue, Feb 07, 2012 6:00 AM Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference - Business Wire Mon, Feb 06, 2012 4:15 PM Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® - Business Wire Fri, Feb 03, 2012 7:00 AM Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke - Business Wire Mon, Jan 09, 2012 6:00 AM Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference - Business Wire Wed, Dec 28, 2011 6:00 AM Acorda Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire Tue, Nov 22, 2011 6:00 AM Acorda Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference - Business Wire Wed, Nov 16, 2011 7:00 AM Acorda Therapeutics Announces Preclinical Data on GGF2 in Heart Failure Presented at American Heart Association Scientific Sessions 2011 - Business Wire Mon, Nov 07, 2011 9:00 AM Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on Acorda Therapeutics Inc. and BioMarin Pharmaceutical Inc. - Marketwire Sun, Oct 23, 2011 10:20 PM Survey: Trouble walking hardest part of MS - UPI Thu, Oct 20, 2011 4:00 AM Survey Finds Majority of People With Multiple Sclerosis Report Difficulty Walking or Maintaining Balance - PR Newswire Tue, Sep 20, 2011 1:20 PM Cannabis Science Appoints New Investor Relations Manager - Marketwire Thu, Oct 15, 2009 8:58 AM The Stock Alarm Issues Morning Alert On Companies That May Have Unusual Moves: Acorda Therapeutics Inc., Cit Group Inc., Lazard Ltd. and WD-40 Co. - Marketwire Canada More News for ACOR >>

Tags for Acorda Therapeutics Inc.

Research stocks or mutual funds related to Acorda Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to ACOR. The keywords below have been associated to ACOR by either user submission or electronic means.

pharmaceutical articles biotech research pharmaceutical branding pharmaceutical publication pharmaceutical market pharmaceuticals clinical trials jobs in pharmaceutical pharmaceuticals careers clinical diagnostics outsourcing clinical trials pharmaceutical research and development pharmaceutical manufacturing company dupont pharmaceuticals pharmaceutical position Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharmaceutical clinical research pfizer careers pharma license novartis pharmaceuticals gmp pharmaceutical clinical research pharmaceutical class pharmaceutical cro pharmaceutical sales pharma pharmaceutical distributors pharmaceutical reports pharmaceutical magazine pharmaceutical consultant biotech worldwide clinical trials Drugs pharmaceutical auctions pharma clinical trials pharmaceutical industry news pharmaceutical manufacturing software clinical trials conference pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmaceutical sale clinical trials europe

 

 

Home | About Us | Contact | Terms of Service | Privacy Policy | Blog

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.